| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Hans van Houte is Chief Financial Officer at NRIX. From February 2021 to October 2026, the filings on record show 0 open-market purchases and 36 sales. Hans van Houte's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Historically, Hans van Houte's trades have earned a middling insider score of 56/100 across 32 rated trades. Over a 12-month horizon, 52.0% of those trades were profitable, with an average 12-month return of -19.2%.
The NRIX filings lean toward selling, a net 207,123 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 6,198 | $11.33 | $70,242.55 | -15.5% | -0.1% | - | |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,438 | $11.50 | $28,041.14 | -5.8% | +3.1% | +44.8% | |
| Mar 3, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 5,825 | $14.49 | $84,387.72 | -14.7% | -14.4% | +11.5% | |
| Jan 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,811 | $19.85 | $55,808.69 | -6.6% | -42.4% | -17.5% | |
| Nov 1, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 3,546 | $24.28 | $86,083.41 | -9.5% | -18.2% | -47.1% | |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,368 | $24.31 | $57,554.24 | -6.0% | -18.7% | -46.9% | |
| Aug 26, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 20,000 | $25.22 | $504,370.00 | -39.2% | -15.1% | -62.9% | |
| Aug 1, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 3,477 | $21.45 | $74,575.91 | -6.4% | +12.1% | -48.6% | |
| Jul 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,490 | $20.67 | $51,462.57 | -4.4% | +27.3% | -42.8% | |
| Jun 20, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 20,000 | $20.01 | $400,216.00 | -29.3% | +18.0% | -45.2% |